Signs you may have bacterial vaginosis: A clinical overview of symptoms and diagnostic indicators
When individuals experience persistent changes in vaginal health, identifying the specific cause is necessary for appropriate management. Bacterial vaginosis (BV) is recognized as the most common infectious vaginitis in women of reproductive age worldwide 4, 5. It is a condition defined by dysbiosis, which is a complex alteration of the vaginal flora where protective lactobacilli decrease in number, allowing anaerobic pathogens to overgrow 1, 5. While many people may remain asymptomatic, recognizing the hallmark signs is important for maintaining reproductive and overall health 2, 4.
Common Indicators and Symptom Presentation
The most widely reported sign of bacterial vaginosis is an increase in vaginal discharge that appears thin and homogeneous 5, 8. This discharge is typically grayish-white or sometimes yellowish-green in color and tends to coat the vaginal walls smoothly 1, 5. Unlike healthy discharge, this manifestation is often accompanied by a distinct, unpleasant odor frequently described as fishy 1, 3. Clinical observations indicate that this odor may become significantly more pronounced following sexual intercourse or during menstruation 3, 9.
Beyond discharge, individuals may experience mild vulvovaginal irritation 5. While some patients report burning during urination or occasional itching, these symptoms are often less intense than those associated with other common vaginal infections, such as yeast infections or thrush 3, 9. A critical clinical reality is that 50% to 80% of women who develop bacterial vaginosis may present with no symptoms at all, meaning the condition often goes unnoticed without professional screening 2, 3.
The Underlying Mechanism of Vaginal Microbiome Imbalance
The healthy vagina relies on lactobacilli to maintain a low pH level, which protects the lining and prevents the colonization of harmful organisms 1, 2. In the case of BV, this protective environment is compromised 2. Anaerobic pathogens, including Gardnerella vaginalis, Peptostreptococcus, and Prevotella species, increase in concentration by 10- to 100-fold, effectively replacing the dominant, beneficial bacteria 1, 5. While the exact triggers for this bacterial shift are not fully understood, it is established that the condition represents a systemic disruption of the local microbial community rather than the presence of a single infectious agent 3, 10.
Clinical Diagnosis and Standardized Criteria
Because symptoms of BV can overlap with other conditions, healthcare providers utilize specific protocols to ensure an accurate diagnosis. The Amsel criteria represent a standard clinical approach, requiring at least three of the following four findings: the presence of thin, homogeneous, grayish-white discharge; an elevated vaginal pH greater than 4.5; the release of a fishy odor upon the addition of 10% potassium hydroxide (KOH) to a sample; and the identification of clue cells-vaginal epithelial cells coated with bacteria-during wet mount microscopy 5, 8. Molecular diagnostic tests are also increasingly used in clinical settings to confirm the bacterial shift 5.

Risk Factors and Complications
Epidemiological data suggest that BV is more common in women who are sexually active, and it is currently categorized as a sexually transmitted infection by many health organizations due to its strong association with sexual activity 1, 5, 7. However, it can occasionally occur in individuals who have not been sexually active 1, 3. Certain practices, including vaginal douching, use of a copper intrauterine device, and nicotine use, have been linked to an increased risk of developing recurrent infections 3, 7. Untreated BV can have significant health implications, including an increased susceptibility to other sexually transmitted infections, pelvic inflammatory disease, and risks during pregnancy, such as preterm birth or chorioamnionitis 4, 5.
Management and Treatment Approaches
Once diagnosed, bacterial vaginosis is typically treated with prescription antibiotics, which are administered either orally or via topical gels and creams containing medications such as metronidazole or clindamycin 1, 5, 7. Because the condition is prone to recurrence, clinicians may sometimes consider treating sexual partners in cases of persistent or recurring infections 5, 7. While strategies like probiotics or condom use are sometimes discussed, there is currently limited evidence that these can reliably prevent the condition from occurring in all cases 3.
Distinguishing BV from Other Infections
It is common for individuals to confuse BV with other conditions, particularly yeast infections (candidiasis), which typically present with intense itching, soreness, redness, and thick, clumpy discharge 9, 10. Because the treatment protocols for these infections differ significantly-with BV requiring antibiotics and yeast infections often managed with antifungals-self-diagnosis is generally discouraged 6, 10. Relying on a clinical evaluation ensures that the specific microbial imbalance is correctly identified and that appropriate therapy is initiated to prevent further complications 4, 6.
Sources
- MSD Manual Consumer Version - Bacterial Vaginosis
- InformedHealth.org - Overview: Bacterial Vaginosis
- Family Doctor - Bacterial Vaginosis (BV)
- StatPearls - Bacterial Vaginosis
- MSD Manual Professional Version - Bacterial Vaginosis
- Harvard Health - Telltale signs of vaginal infections
- Merck Manual Consumer Version - Editorial: Bacterial Vaginosis
- StatPearls - Amsel Criteria
- Vyta.co - Bacterial Vaginosis Symptoms
- HealthSpectra - Bacterial Vaginosis Symptoms: What to Look For
Authored by MyTrendSpot team